Enhance your practice with CME and tools that focus on the management of neurological conditions.
Uncovering TK2d: How to Navigate Diagnostic Challenges
Kaitlin Batley, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Discharge Planning After Myasthenic Crisis
New Therapies, New Strategy: Rethinking MG Inpatient Care
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Navigating Emerging Biomarkers in MS Care
Ethan Meltzer, MD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Exploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
Immunologic Phenotyping: The Future of Personalized MG Care
A Closer Look at the Biology Behind MS Progression
More Than a Myopathy: The Lived Experience of TK2d
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Ryan Quigley
ADHD After 25 Years: What Have We Learned?
James Swanson, PhD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.